Revolution Medicines Statistics
Total Valuation
RVMD has a market cap or net worth of $38.71 billion. The enterprise value is $37.24 billion.
Important Dates
The next estimated earnings date is Wednesday, August 5, 2026, after market close.
| Earnings Date | Aug 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
RVMD has 212.60 million shares outstanding. The number of shares has increased by 10.96% in one year.
| Current Share Class | 212.60M |
| Shares Outstanding | 212.60M |
| Shares Change (YoY) | +10.96% |
| Shares Change (QoQ) | +0.73% |
| Owned by Insiders (%) | 2.27% |
| Owned by Institutions (%) | 87.68% |
| Float | 194.09M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 138.73 |
| PB Ratio | 24.30 |
| P/TBV Ratio | 27.08 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.80, with a Debt / Equity ratio of 0.29.
| Current Ratio | 6.80 |
| Quick Ratio | 6.59 |
| Debt / Equity | 0.29 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -38.07 |
Financial Efficiency
Return on equity (ROE) is -76.67% and return on invested capital (ROIC) is -41.78%.
| Return on Equity (ROE) | -76.67% |
| Return on Assets (ROA) | -37.53% |
| Return on Invested Capital (ROIC) | -41.78% |
| Return on Capital Employed (ROCE) | -70.61% |
| Weighted Average Cost of Capital (WACC) | 11.92% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.55M |
| Employee Count | 883 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +374.04% in the last 52 weeks. The beta is 1.41, so RVMD's price volatility has been higher than the market average.
| Beta (5Y) | 1.41 |
| 52-Week Price Change | +374.04% |
| 50-Day Moving Average | 151.23 |
| 200-Day Moving Average | 98.50 |
| Relative Strength Index (RSI) | 73.55 |
| Average Volume (20 Days) | 3,628,410 |
Short Selling Information
The latest short interest is 11.59 million, so 5.45% of the outstanding shares have been sold short.
| Short Interest | 11.59M |
| Short Previous Month | 11.08M |
| Short % of Shares Out | 5.45% |
| Short % of Float | 5.97% |
| Short Ratio (days to cover) | 4.52 |
Income Statement
| Revenue | n/a |
| Gross Profit | -1.13B |
| Operating Income | -1.39B |
| Pretax Income | -1.37B |
| Net Income | -1.37B |
| EBITDA | -1.38B |
| EBIT | -1.39B |
| Earnings Per Share (EPS) | -$7.12 |
Full Income StatementBalance Sheet
The company has $1.91 billion in cash and $437.27 million in debt, giving a net cash position of $1.47 billion or $6.92 per share.
| Cash & Cash Equivalents | 1.91B |
| Total Debt | 437.27M |
| Net Cash | 1.47B |
| Net Cash Per Share | $6.92 |
| Equity (Book Value) | 1.50B |
| Book Value Per Share | 7.49 |
| Working Capital | 1.68B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$1.06 billion and capital expenditures -$14.26 million, giving a free cash flow of -$1.07 billion.
| Operating Cash Flow | -1.06B |
| Capital Expenditures | -14.26M |
| Depreciation & Amortization | 8.44M |
| Net Borrowing | n/a |
| Free Cash Flow | -1.07B |
| FCF Per Share | -$5.04 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |